Your browser doesn't support javascript.
loading
Double or Simple Emulsion Process to Encapsulate Hydrophilic Oxytocin Peptide in PLA-PEG Nanoparticles.
Gourdon, Betty; Declèves, Xavier; Péan, Jean-Manuel; Chemin, Caroline.
Afiliação
  • Gourdon B; Technologie Servier, 27 rue Eugène Vignat, Orléans, France.
  • Declèves X; Inserm, U1144, F-75006, Paris, France.
  • Péan JM; Faculté de Pharmacie de Paris, UMR-S 1144, Université Paris Descartes, F-75006, Paris, France.
  • Chemin C; Inserm, U1144, F-75006, Paris, France. xavier.decleves@parisdescartes.fr.
Pharm Res ; 35(4): 82, 2018 Mar 05.
Article em En | MEDLINE | ID: mdl-29508092
PURPOSE: Oral drug delivery using NPs is a current strategy for poorly absorbed molecules. It offers significant improvement in terms of bioavailability. However, the encapsulation of proteins and peptides in polymeric NPs is a challenge. Firstly, the present study focused on the double emulsion process in order to encapsulate the OXY peptide. Then the technique was challenged by a one-step simplified process, the simple emulsion. METHODS: In order to study the influence of formulation and process parameters, factorial experimental designs were carried on. The responses observed were the NP size (<200 nm in order to penetrate the intestinal mucus layer), the suspension stability (ZP < |30| mV) and the OXY loading. RESULTS: It was thus found that the amount and the nature of surfactant, the ratio between the phases, the amount of PLA-PEG polymer and OXY, the presence of a viscosifying agent, and the duration of the sonication could significantly influence the responses. Finally, OXY-loaded NPs from both processes were obtained with NP size of 195 and 226 nm and OXY loading of 4 and 3.3% for double and simple emulsions, respectively. CONCLUSION: The two processes appeared to be suitable for OXY encapsulation and comparable in term of NP size, peptide drug load and release obtained.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ocitocina / Portadores de Fármacos / Composição de Medicamentos / Liberação Controlada de Fármacos Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ocitocina / Portadores de Fármacos / Composição de Medicamentos / Liberação Controlada de Fármacos Idioma: En Ano de publicação: 2018 Tipo de documento: Article